Navigation Links
Nepstar Chain Drugstore (NPD) Greenshoe Fully Exercised
Date:11/15/2007

SHENZHEN, China, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the underwriters of the Company's initial public offering ("IPO") have exercised their greenshoe option in full to purchase 3,093,750 American Depositary Shares ("ADSs") from the Company at the IPO price of US$16.20 per ADS less the underwriting discount. The option was granted in connection with the Company's IPO, which was priced on November 8, 2007.

Including proceeds from the exercise of the greenshoe option, gross proceeds from the Company's IPO would increase to approximately US$384.2million.

Jiannong Qian, Nepstar's Chief Executive Officer, said: "We are delighted that investors have received our ADSs warmly. The funds raised from our IPO will enable us to further expand our store network and take other measures to reinforce our leading position in China's retail drugstore industry."

Goldman Sachs (Asia) L.L.C. was the sole global coordinator of the offering. Goldman Sachs (Asia) L.L.C. and Merrill Lynch, Pierce, Fenner & Smith Incorporated were the joint bookrunners. CLSA Limited was a co-manager of the offering.

Nepstar's registration statement relating to these securities has been declared effective by the United States Securities and Exchange Commission. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of the securities is made only by means of a prospectus forming a part of the effective registration statement. A copy of the prospectus relating to the offering may be obtained by contacting Goldman Sachs & Co. by mail, Attn: Prospectus Department, 85 Broad Street, New York, NY 10004, facsimile: +1-212-902-9316, email: prospectus-ny@ny.email.gs.com.

For more information, please contact:

In Shenzhen:

Lucia Qian

China Nepstar Drugstore Chain Ltd

Tel: +86-755-2641-4065

Email: qianrt@nepstar.cn

In New York:

Ivette Almeida

The Global Consulting Group

Tel: +1-646-284-9455

Email: ialmeida@hfgcg.com

In Hong Kong:

Bruce Shu

Citigate Dewe Rogerson

Tel: +852-2533-4607

Email: bruce.shu@citigate.com.hk


'/>"/>
SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE
2. With the Largest-Ever Buyout of a National Nursing Home Chain Pending ... New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
3. NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains
4. IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
5. SEIU Launches Multi-State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nations Largest Nursing Home Chain
6. Demonstration at Carlyle Group Offices Monday as Grassroots Caravan of Caregivers, Senior Advocates Arrives in D.C. to Speak Out for Improved Care, Staffing at Nations Largest Nursing Home Chain
7. DoD and VA to Reduce Healthcare Supply Chain Costs
8. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
9. PCMA Statement on the Independent Drugstore Lobby Agenda
10. drugstore.com and Revolution Health Group Announce Breakthrough Deal
11. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... ... 2016 , ... Spine Team Texas, a comprehensive spine physician group specializing in ... physicians has been invited to be a featured speaker at the Texas Society of ... April 30, 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of ... improve smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the ... to learn more about the options currently available to them and which ones might ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
Breaking Medicine Technology: